Sign in
4

Changes in Ownership

SUTRO BIOPHARMA, INC. Filed Acc 0001992979-26-000002

CHIEF SCIENTIFIC OFFICER gave up 1,633 shares (to pay taxes)

  • CHIEF SCIENTIFIC OFFICER acquired 3,968 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2026-03-01 Option exercise +1,125 8,308 D
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2026-03-01 Shares withheld for taxes −463 $20.47 $9,478 7,845 D
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2026-03-02 Option exercise +2,843 10,688 D
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2026-03-02 Shares withheld for taxes −1,170 $20.55 $24,044 9,518 D
Derivatives
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2026-03-01 Option exercise · Restricted Stock Units (RSUs) −1,125 2,250 D
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2026-03-02 Option exercise · Restricted Stock Units (RSUs) −2,843 8,532 D
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2026-03-02 Grant or award · Restricted Stock Units (RSUs) +5,000 5,000 D
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2026-03-02 Grant or award · Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X05/form4-03032026_110346.xml…